ELENI EFSTATHIOU to Cytochrome P-450 Enzyme Inhibitors
This is a "connection" page, showing publications ELENI EFSTATHIOU has written about Cytochrome P-450 Enzyme Inhibitors.
Connection Strength
0.150
-
Updated interim efficacy analysis and long-term safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy (COU-AA-302). Eur Urol. 2014 Nov; 66(5):815-25.
Score: 0.118
-
Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial. Lancet Oncol. 2015 Mar; 16(3):338-48.
Score: 0.032